Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Open in API
Filings indexed 708 across all filing types
Latest filing 2020-03-26 Regulatory Filings
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1498 characters) and contains an 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action (like DIV or ER). Since it is a direct, time-sensitive announcement disseminated via the London Stock Exchange's regulatory news service (RNS) and does not fit any other specific category (like DIRS, MANG, or DIV), it falls best under the general regulatory announcement category.
2020-03-26 English
Price Monitoring Extension
Share Issue/Capital Change Classification · 99% confidence The document is very short (1481 characters) and contains an 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content itself is a specific, brief operational announcement regarding a 'Price Monitoring Extension' on a security's trading auction call. This type of brief, regulatory-mandated operational update that doesn't fit into specific financial reporting categories (like 10-K, ER, or IR) is best classified as a general Regulatory Filing, which corresponds to the RNS code.
2020-03-26 English
Second Price Monitoring Extn
Share Issue/Capital Change Classification · 99% confidence The document is very short (1498 characters) and contains the header 'RNS Number : 4109H'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. This type of immediate, short-form regulatory notification that does not contain detailed financial reports or management changes fits best under the general regulatory announcement category, which is RNS (Regulatory Filings). It is not a specific report like 10-K, ER, or IR, nor is it a dividend notice or director dealing report. It is a general market operational announcement.
2020-03-24 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1481 characters) and contains an RNS Number, indicating it is a regulatory announcement from the London Stock Exchange. The content specifically discusses a 'Price Monitoring Extension' and an 'auction call period extension' for a security. This type of operational market notice, which does not fit into specific financial reporting categories (like 10-K, ER, or DIV), is best classified under the general regulatory announcement category, RNS, as per the definitions and the 'Menu vs Meal' rule (it's an announcement, not a detailed report).
2020-03-24 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1498 characters) and contains the header 'RNS Number : 3505G' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' for a security, which is a specific, immediate operational announcement related to trading status, not a comprehensive financial report or a standard corporate filing like 10-K or ER. Since it is a direct, non-standard regulatory announcement distributed via the RNS system, and it doesn't fit into the more specific categories (like DIV, DIRS, or ER), the most appropriate classification is the general Regulatory Filings category (RNS).
2020-03-16 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1481 characters) and contains the header 'RNS Number : 3424G'. It announces a 'Price Monitoring Extension' related to trading activity on the London Stock Exchange. This is a general regulatory announcement that does not fit the specific definitions for financial reports (10-K, IR, ER), management changes (MANG), or shareholder actions (DIV, DVA). Since it is a standard notification provided by RNS (the news service of the London Stock Exchange) and serves as a general regulatory update, the most appropriate classification is Regulatory Filings (RNS).
2020-03-16 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.